Advanced Biomed Inc. Common Stock (ADVB) vs Valion Bio, Inc. (VBIO)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and Valion Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VBIO
Valion Bio, Inc.
$2.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ADVB vs VBIO
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)VBIO -97.7% (-84.9%/yr)ADVB compounded faster over this window
ADVB VBIO
ADVB vs VBIO: by the numbers
- •VBIO is the larger company ($10M vs $9M market cap).
Metrics side by side
Valuation
| Metric | ADVB | VBIO |
|---|---|---|
| P/B ratio | 0.96 | 2.32 |
Profitability
| Metric | ADVB | VBIO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -7.36% | -157.76% |
| ROIC | -11.06% | -55.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.